Resmed (RSMDF) Other Non Operating Income (2009 - 2026)

Resmed has reported Other Non Operating Income for 18 years, with the latest figure at -$1.4 million in Q1 2026.

• For the quarter ending Q1 2026, Other Non Operating Income rose 66.15% year-over-year to -$1.4 million; the trailing twelve-month figure through Mar 2026 stood at -$11.5 million (down 58.56% YoY), and the FY2025 full-year result was -$5.3 million, down 50.43% from the prior year.
• Other Non Operating Income for Q1 2026 stood at -$1.4 million, up from -$5.3 million in the prior quarter.
• The five-year high for Other Non Operating Income was $2.6 million in Q3 2023, with the low at -$5.3 million in Q4 2025.
• Historically, Other Non Operating Income has averaged -$1.2 million across 5 years, with a median of -$1.5 million in 2022.
• The largest YoY upside for Other Non Operating Income was 423.03% in 2024 against a maximum downside of 4947.54% in 2024.
• Resmed's Other Non Operating Income stood at -$1.7 million in 2022, then jumped by 59.81% to -$686000.0 in 2023, then soared by 423.03% to $2.2 million in 2024, then plunged by 338.36% to -$5.3 million in 2025, then surged by 74.01% to -$1.4 million in 2026.
• The last three Other Non Operating Income figures came in at -$1.4 million (Q1 2026), -$5.3 million (Q4 2025), and -$3.8 million (Q3 2025), per Business Quant data.